The growth of the cardiovascular ultrasound system market is propelled by increasing incidence of CVDs, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures. However, factors such as insufficient reimbursement scenario and economic impact of adopting new technologies are hindering the growth of the market.

The major key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50389652

Target Audience:

• Cardiovascular ultrasound system manufacturers
• Cardiovascular ultrasound system distributors and wholesalers
• Pharmaceutical companies
• Various research and consulting firms
• Research institutes
• Contract manufacturing organizations (CMOs)
• Original equipment manufacturers (OEMs)

Recent Developments:

• In 2015, GE Healthcare signed a memorandum of understanding with the Oregon Health & Science University (U.S.) to undertake collaborative R&D studies in the field of cardiovascular imaging & treatment as well as in big data research
• In 2015, GE Healthcare launched a new 4D cardiac ultrasound software—cSound—for three new ultrasound systems, namely, VividS70, VividE90, and VividE95 in the U.S. and some countries in Europe, Asia, and LatinAmerica.

Key Market Players

Key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).